Drug Development from Marine Resources

Marine organisms, including sponges, corals, and marine microbes, are a rich source of novel bioactive compounds with therapeutic potential. Marine-derived drugs have shown promise in treating a variety of diseases, particularly cancer, infections, and neurodegenerative disorders. Compounds like trabectedin (anticancer) and eflornithine (antimalarial) highlight the success of marine bioprospecting. Advances in marine biotechnology now enable sustainable production of these compounds, overcoming challenges in sourcing and scaling. With ongoing research and innovations in drug delivery systems and biotechnology, marine resources continue to provide valuable leads for the development of new, effective pharmaceuticals.

 

    Related Conference of Drug Development from Marine Resources

    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 21-22, 2025

    24th International Conference on Genomics and Molecular Biology

    Aix-en-Provence, France
    July 21-22, 2025

    11th World Congress on Anesthesia and Critical Care

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    October 16-17, 2025

    19th International Conference on Pathology and Laboratory Medicine

    Aix-en-Provence, France
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy

    Drug Development from Marine Resources Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in